fb777 001
By ADRIANA GOMEZ LICON FORT LAUDERDALE, Fla. — Republican senators pushed back on Sunday against criticism from Democrats that , Donald Trump’s pick to lead , is “compromised” by and , as a congresswoman, with Syria’s president, a close ally of the Kremlin and Iran. Sen. Tammy Duckworth, an Illinois Democrat and veteran of combat missions in Iraq, said she had concerns about Tulsi Gabbard, Trump’s choice to be . “I think she’s compromised,” Duckworth said on CNN’s “State of the Union,” citing Gabbard’s 2017 trip to Syria, where she held talks with Syrian President Bashar Assad. Gabbard was a Democratic House member from Hawaii at the time. “The U.S. intelligence community has identified her as having troubling relationships with America’s foes. And so my worry is that she couldn’t pass a background check,” Duckworth said. Gabbard, who said last month she is joining the Republican Party, has served in the Army National Guard for more than two decades. She was deployed to Iraq and Kuwait and, according to the Hawaii National Guard, a Combat Medical Badge in 2005 for “participation in combat operations under enemy hostile fire in support of Operation Iraqi Freedom III.” Duckworth’s comments drew immediate backlash from Republicans. “For her to say ridiculous and outright dangerous words like that is wrong,” Sen. Markwayne Mullin, a Republican from Oklahoma, said on CNN, challenging Duckworth to retract her words. “That’s the most dangerous thing she could say — is that a United States lieutenant colonel in the United States Army is compromised and is an asset of Russia.” In recent days, other Democrats have accused Gabbard without evidence of being a “Russian asset.” Sen. Elizabeth Warren, a Massachusetts Democrat, has claimed, without offering details, that Gabbard is in Russian President Vladimir “Putin’s pocket.” Mullin and others say the criticism from Democrats is rooted in the fact that Gabbard left their party and has become a Trump ally. Democrats say they worry that Gabbard’s selection as national intelligence chief endangers ties with allies and gives Russia a win. Rep. Adam Schiff, a California Democrat just elected to the Senate, said he would not describe Gabbard as a Russian asset, but said she had “very questionable judgment.” “The problem is if our foreign allies don’t trust the head of our intelligence agencies, they’ll stop sharing information with us,” Schiff said on NBC’s “Meet the Press.” Gabbard in 2022 endorsed one of Russia’s justifications for : the existence of working on some of the world’s nastiest pathogens. The labs are part of an international effort to control outbreaks and stop bioweapons, but Moscow claimed Ukraine was using them to create deadly bioweapons. Gabbard said she just voiced concerns about protecting the labs. Gabbard also has suggested that Russia had legitimate security concerns in deciding to invade Ukraine, given its desire to join NATO. Republican Sen. Eric Schmitt of Missouri said he thought it was “totally ridiculous” that Gabbard was being cast as a Russian asset for having different political views. “It’s insulting. It’s a slur, quite frankly. There’s no evidence that she’s a asset of another country,” he said on NBC. Sen. James Lankford, another Oklahoma Republican, acknowledged having “lots of questions” for Gabbard as the Senate considers her nomination to lead the intelligence services. Lankford said on NBC that he wants to ask Gabbard about her meeting with Assad and some of her past comments about Russia. “We want to know what the purpose was and what the direction for that was. As a member of Congress, we want to get a chance to talk about past comments that she’s made and get them into full context,” Lankford said.Connor Clark & Lunn Investment Management Ltd. increased its holdings in shares of Option Care Health, Inc. ( NASDAQ:OPCH – Free Report ) by 438.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 145,257 shares of the company’s stock after buying an additional 118,292 shares during the period. Connor Clark & Lunn Investment Management Ltd. owned 0.09% of Option Care Health worth $4,547,000 at the end of the most recent quarter. Several other large investors have also bought and sold shares of the business. CANADA LIFE ASSURANCE Co lifted its stake in shares of Option Care Health by 1.8% in the 1st quarter. CANADA LIFE ASSURANCE Co now owns 134,305 shares of the company’s stock valued at $4,503,000 after purchasing an additional 2,355 shares during the period. CreativeOne Wealth LLC lifted its stake in Option Care Health by 24.9% in the first quarter. CreativeOne Wealth LLC now owns 10,885 shares of the company’s stock valued at $365,000 after buying an additional 2,173 shares during the period. BOKF NA boosted its holdings in Option Care Health by 13.5% during the first quarter. BOKF NA now owns 47,139 shares of the company’s stock worth $1,546,000 after buying an additional 5,589 shares during the last quarter. Price T Rowe Associates Inc. MD grew its position in shares of Option Care Health by 1.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 1,760,482 shares of the company’s stock worth $59,047,000 after buying an additional 23,676 shares during the period. Finally, Janus Henderson Group PLC increased its stake in shares of Option Care Health by 182.9% in the 1st quarter. Janus Henderson Group PLC now owns 227,135 shares of the company’s stock valued at $7,617,000 after acquiring an additional 146,837 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds. Option Care Health Trading Up 2.8 % OPCH opened at $23.13 on Friday. The stock has a market capitalization of $3.94 billion, a P/E ratio of 19.44, a P/E/G ratio of 2.33 and a beta of 1.32. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $34.63. The firm’s fifty day simple moving average is $27.62 and its 200 day simple moving average is $29.10. Insider Activity Analysts Set New Price Targets Several research firms recently weighed in on OPCH. Barrington Research reduced their price objective on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research note on Thursday, October 31st. JMP Securities lifted their price target on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research report on Monday, September 30th. Truist Financial lowered their price objective on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Jefferies Financial Group lowered Option Care Health from a “buy” rating to a “hold” rating and reduced their target price for the stock from $38.00 to $26.00 in a report on Thursday, October 31st. Finally, Bank of America cut Option Care Health from a “buy” rating to a “neutral” rating and decreased their target price for the company from $43.00 to $29.00 in a research note on Wednesday, October 30th. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, Option Care Health has a consensus rating of “Moderate Buy” and an average price target of $30.83. View Our Latest Stock Report on Option Care Health Option Care Health Profile ( Free Report ) Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. Featured Stories Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. ( NASDAQ:OPCH – Free Report ). Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter .
Lindsay Corporation Stock Hits 52-Week High at $135.17
